# Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults

> **NCT02231281** · PHASE3 · UNKNOWN · sponsor: **Yongtao Sun, MD, PhD** · enrollment: 65 (estimated)

## Conditions studied

- Acute HIV Infection

## Interventions

- **DRUG:** cART(TDF/AZT+3TC+LPV/r)
- **PROCEDURE:** CTL infusion

## Key facts

- **NCT ID:** NCT02231281
- **Lead sponsor:** Yongtao Sun, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-08
- **Primary completion:** 2018-08
- **Final completion:** 2018-12
- **Target enrollment:** 65 (ESTIMATED)
- **Last updated:** 2018-04-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02231281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02231281, "Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT02231281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*